CD34 and Huntington disease: The direct comparison of BM- or MPB-derived CD34+ cell composition before transduction by using either the conventional or the alternative gating strategy, revealed that the alternative approach was not able to measure the differences in CD34+ cell composition between the two sources (Supplementary Fig. 3a–d) in both HD and WAS patients’ samples.